• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

报告发热性中性粒细胞减少患者经验性抗生素随机试验的结果——一项批判性调查。

Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.

作者信息

Pater J L, Weir L

出版信息

J Clin Oncol. 1986 Mar;4(3):346-52. doi: 10.1200/JCO.1986.4.3.346.

DOI:10.1200/JCO.1986.4.3.346
PMID:3512784
Abstract

Twenty-one randomized trials of empiric antibiotic therapy in febrile neutropenic patients were reviewed and scored by methods suggested by Chalmers. In general, the scores were low, indicating that many of these articles failed to meet currently suggested methodologic standards for publication of results of clinical trials. Particularly striking was the lack of attention paid to statistical issues, such as power, exclusions, and repeated analyses. In addition, there appears to be a need for a better-developed system for assessing response in these circumstances.

摘要

我们采用查尔默斯提出的方法,对21项关于发热性中性粒细胞减少患者经验性抗生素治疗的随机试验进行了综述和评分。总体而言,评分较低,这表明这些文章中有许多未能达到目前建议的临床试验结果发表的方法学标准。尤其引人注目的是,对统计学问题缺乏关注,如检验效能、排除标准和重复分析。此外,似乎需要一个更完善的系统来评估这些情况下的反应。

相似文献

1
Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.报告发热性中性粒细胞减少患者经验性抗生素随机试验的结果——一项批判性调查。
J Clin Oncol. 1986 Mar;4(3):346-52. doi: 10.1200/JCO.1986.4.3.346.
2
The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
Clin Invest Med. 1988 Oct;11(5):327-30.
3
Statistical considerations in clinical trials testing empiric antibiotic regimens in patients with febrile neutropenia.
Support Care Cancer. 1998 Sep;6(5):438-43. doi: 10.1007/s005200050191.
4
Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
J Hosp Infect. 1990 Apr;15 Suppl A:41-8. doi: 10.1016/0195-6701(90)90078-3.
5
A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.一项针对发热性中性粒细胞减少患者,使用四种β-内酰胺类抗生素之一联合奈替米星进行经验性抗生素治疗的随机试验。
J Antimicrob Chemother. 1988 Aug;22(2):237-47. doi: 10.1093/jac/22.2.237.
6
Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.发热性粒细胞缺乏症患者的经验性抗真菌治疗。欧洲癌症研究与治疗组织国际抗菌治疗合作组。
Am J Med. 1989 Jun;86(6 Pt 1):668-72. doi: 10.1016/0002-9343(89)90441-5.
7
Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
Support Care Cancer. 1996 Sep;4(5):358-63. doi: 10.1007/BF01788842.
8
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.在对发热性中性粒细胞减少的癌症儿童进行经验性治疗时,将万古霉素、替卡西林和阿米卡星与替卡西林-克拉维酸和阿米卡星进行比较。
N Engl J Med. 1988 Oct 20;319(16):1053-8. doi: 10.1056/NEJM198810203191604.
9
Gentamicin and low dose piperacillin in febrile neutropenic patients.庆大霉素与低剂量哌拉西林用于发热性中性粒细胞减少症患者。
J Antimicrob Chemother. 1989 Jul;24(1):45-51. doi: 10.1093/jac/24.1.45.
10
Management in the febrile, neutropenic patient with cancer: therapeutic considerations.癌症发热性中性粒细胞减少患者的管理:治疗考量
J Pediatr. 1985 Jun;106(6):1035-42. doi: 10.1016/s0022-3476(85)80265-1.

引用本文的文献

1
Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products.一种用于对天然产物随机对照试验进行批判性评价的工具的开发与评估。
BMC Complement Altern Med. 2009 Apr 23;9:11. doi: 10.1186/1472-6882-9-11.
2
Use of the quinolones in the prophylaxis and treatment of granulocytopenic immunocompromised cancer patients.喹诺酮类药物在粒细胞减少免疫功能低下癌症患者预防和治疗中的应用。
Drugs. 1993;45 Suppl 3:81-90. doi: 10.2165/00003495-199300453-00015.